pSivida Corp (NASDAQ:PSDV)
| 3.08 Data as of May 23 |  +0.08 / +2.67%Today’s Change | 1.17 Today|||52-Week Range 3.50 | +154.55% Year-to-Date |
Latest PSDV News | Press Releases
No recent news for pSivida Corp.
Today’s Trading
| Previous close | 3.00 |
| Today’s open | 3.01 |
| Day’s range | 3.00 - 3.18 |
| Volume | 237,298 |
| Average volume (3 months) | 149,207 |
| Market cap | $69.9M |
| Dividend yield | -- |
Data as of 4:00pm ET, 05/23/2013
Growth & Valuation
| Earnings growth (last year) | -170.45% |
| Earnings growth (this year) | +63.90% |
| Earnings growth (next 5 years) | +0.00% |
| Revenue growth (last year) | -28.98% |
| P/E ratio | NM |
| Price/Sales | 13.62 |
| Price/Book | 4.58 |
Competitors
| Today’s change | Today’s % change | |
|---|---|---|
| CYTRCytRx Corp | +0.03 | +1.30% |
| LPTNLpath Inc | +0.07 | +1.44% |
| PIPPharmAthene Inc | -0.01 | -0.92% |
| DRIOLabStyle Innovations... | -0.01 | -0.33% |
Data as of 4:01pm ET, 05/23/2013
Financials
| Next reporting date | September 23, 2013 |
| EPS forecast (this quarter) | -$0.11 |
| Annual revenue (last year) | $3.5M |
| Annual profit (last year) | -$24.8M |
| Net profit margin | -704.34% |
Profile
Sector Health Technology |
Industry Biotechnology |
President, Chief Executive Officer & Director Paul Ashton, PhD |
Vice President- Operations Marty Nazzaro |
Corporate headquarters Waterson, Massachusetts |
Forecasts
